The journal Antibiotics published a review on the prospects and challenges of using bacteriophages in patients with treatment-resistant chronic rhinosinusitis. The review presents the results of preclinical and clinical studies in this area.
Bacteriophages have great potential in treating patients with joint prosthesis infections, as they act synergistically with antibiotics to destroy biofilms. A clinical case of treating a recurrent joint prosthesis infection caused by Pseudomonas aeruginosa was published in the journal Frontiers in Medicine.
The journal "Medical Perspectives" No. 4, 2020, published the results of a study on the sensitivity of Staphylococcus aureus , including MRSA, to the drug "Pyofag® polyvalent bacteriophage" and the use of the drug for the treatment of furunculosis caused by MRSA.
The article "Possibility of using a polyvalent bacteriophage in the technology of delayed antibiotic administration in patients with acute rhinosinusitis" will be published in issue No. 4, 2020, of the international journal "Otolaryngology. Eastern Europe."
Doctors from the Giorgi Eliava Phage Therapy Center (Tbilisi, Georgia) published an article* describing four clinical cases of phage therapy for surgical wounds. We present one of them: the treatment of chronic osteomyelitis.
Doctors from the Giorgi Eliava Phage Therapy Center (Tbilisi, Georgia) described four clinical cases of phage therapy for surgical wounds. We present one of them: the treatment of a diabetic foot infected with multidrug-resistant bacterial strains.
An adjuvant is a substance added to drugs or vaccines to accelerate and enhance the action of the main component. The use of adjuvants for bacteriophages is intended to enhance their antimicrobial action and/or block the development of resistance in target bacteria.
Patients who have undergone cardiac surgery have a very high risk of infectious complications, which can be fatal. In cases of antibiotic-resistant infections, phage therapy may be a solution.
The journal Antibiotics describes a clinical case of successful treatment with bacteriophages of a chronic joint prosthesis infection caused by methicillin-resistant Staphylococcus aureus (MRSA)
GINA – the Global Initiative Against Asthma – has published an updated report on the global strategy for asthma management and prevention (2020 GINA Report, Global Strategy for Asthma Management and Prevention)
The European Rhinological Society has published updated guidelines for the treatment of acute and chronic sinusitis and nasal polyps in children and adults (European Position Paper on Rhinоsinusitis and Nasal Polyps - EPOS 2020)
The drug Pyobacteriophage polyvalent purified can be used for the prevention and treatment of infectious and inflammatory complications in percutaneous nephrolithotripsy as an alternative to antibiotics.
The scientific and practical conference "Current issues in pulmonology and allergology - paths to therapeutic success in the context of interdisciplinary problems" will be held on March 28, 2020, online.
Australian doctors tested a combination of bacteriophages and antibiotics in the treatment of infective endocarditis of a prosthetic valve. The phage preparation was administered intravenously.
In March 2019, the journal Medicinal Research Reviews published a review* summarizing all available data on the pharmacokinetics of bacteriophages. The review was authored by Krystyna Dąbrowska.
Mary Ann Liebert, Inc., announced the launch of PHAGE: Therapy, Applications, and Research, a new peer-reviewed journal dedicated to bacteriophage research and its applications in medicine, agriculture, and the food industry.
The IX International Conference "Bioresources and Viruses" will be held in Kyiv from September 9-11, 2019. Topics for discussion include bacterial viruses.
Presentation by the Head of the Department of Microbiology, Virology, and Immunology of the A.A. Bogomolets National Medical University, Academician of the National Academy of Sciences and the National Academy of Medical Sciences of Ukraine, Professor V.P. Shirobokov at the International Congress "Rational Use of Antibiotics. Antibiotic Resistance Stop!"
